We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Bacterial Persistence to Antibiotic Treatment Mediated by HipA Toxin Inhibition of Glutamyl-tRNA-Synthetase Activity

By LabMedica International staff writers
Posted on 06 Jan 2014
Print article
A team of molecular microbiologists has identified the molecular pathway that induces some types of "persistent" bacteria to enter a static or dormant phase when faced with antibiotic treatment.

Bacterial persistence or multidrug tolerance is caused by a small subpopulation of microbial cells termed persisters. Persisters, which are the main cause for relapsing and chronic infections, are not mutants, but rather are dormant cells that can survive the antimicrobial treatments that kill the majority of their genetically identical siblings. Persister cells have entered a non- or extremely slow-growing physiological state, which makes them insensitive to the action of antimicrobial drugs. When such persisting microbial cells cannot be eliminated by the immune system, they become a reservoir from which recurrence of infection will develop.

In a recent study investigators at the Hebrew University of Jerusalem (Israel) searched for a molecular explanation for bacterial persistence by screening an expression library for putative targets of HipA, the first toxin linked to persistence. HipA belongs to a family of phosphatidylinositide and protein kinases and is capable of autophosphorylation. It causes inhibition of macromolecular synthesis, but the mechanism of action is unknown. Mutants of HipA lacking either predicted active-site residues or the site of autophosphorylation are defective in producing multidrug-tolerant cells.

The investigators reported in the December 17, 2013, online edition of the journal Nature Communications that GltX, the glutamyl-tRNA-synthetase, reversed the toxicity of HipA and prevented the development of persistent forms. GltX is a member of the enzyme family that catalyzes the attachment of an amino acid to its cognate transfer RNA molecule in a highly specific two-step reaction.

Upon HipA expression, GltX activity was blocked, as the enzyme was phosphorylated at Ser239 (amino acid serine residue 239), its ATP-binding site. This phosphorylation led to accumulation of uncharged tRNA(Glu) in the cell, which resulted in the activation of the stringent response. The stringent response is a stress response of bacteria and plant chloroplasts in reaction to amino-acid starvation, fatty acid limitation, iron limitation, heat shock, and other stress conditions. The stringent response modulates transcription of up to one-third of all genes in the cell. This in turn causes the cell to divert resources away from growth and division and toward amino acid synthesis in order to promote survival until nutrient conditions improve.

The investigators stated that, "Our findings demonstrate a mechanism for persister formation by the hipBA toxin-antitoxin module and provide an explanation for the long-observed connection between persistence and the stringent response."

Related Links:

Hebrew University of Jerusalem


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new AI tool can help beat brain tumors (Photo courtesy of Crystal Light/Shutterstock)

New AI Tool Classifies Brain Tumors More Quickly and Accurately

Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more